Strategy Notes
The venture's focus on predicting drug resistance mutations from protein sequence alone aligns with the UKRI's interest in supporting innovative research and innovation leaders. The founder's background as a pharmacist-turned-ML engineer and the venture's pre-seed stage make them a strong candidate for the Future Leaders Fellowships. However, the geography requirement is limited to the UK, which may not be the primary target for the venture.